Back to Search Start Over

Safety of olanzapine at doses higher than 20 mg/day versus typical antipsychotics in the treatment of schizophrenic in-patients (EUROPA study)

Authors :
Gasco´n, J.
Ciudad, A.
A´lvarez, E.
Bobes, J.
Can˜as, F.
Carrasco, J.L.
Gibert, J.
Go´mez, J.C.
Gutie´rrez, M.
Source :
European Neuropsychopharmacology; 2001, Vol. 11 Issue: 1 pS270-S270, 1p
Publication Year :
2001

Details

Language :
English
ISSN :
0924977X
Volume :
11
Issue :
1
Database :
Supplemental Index
Journal :
European Neuropsychopharmacology
Publication Type :
Periodical
Accession number :
ejs3743984
Full Text :
https://doi.org/10.1016/S0924-977X(01)80332-1